DHA Pharmacist Exam Study Material 2026: Books, Topics and 8-Week Plan
DHA Pharmacist Study Material Quick Summary
The DHA Pharmacist paper is a Prometric CBT of clinical cases: drug interactions, dose adjustment, calculations, OTC counselling, pharmacy law and medication safety. You do not need a shelf of books. One therapeutics text, one calculations book, a reliable drug reference and plenty of timed questions cover the syllabus for most candidates in 8 weeks.
DHA lists the content areas and study references for each title in its CBT guideline inside Sheryan. For pharmacists, the paper is built around these areas:
Area
What to know well
Pharmacotherapy
First-line drugs for hypertension, diabetes, asthma, infections, pain, GI and psychiatric conditions; when to refer
Drug interactions and adverse effects
CYP450 inhibitors and inducers, QT prolongation, serotonin syndrome, nephrotoxic and hepatotoxic drugs
Cough and cold, allergy, skin, GI and pain products; red flags for referral
Special populations
Pregnancy, breastfeeding, children, elderly, renal and hepatic impairment
Pharmacy law and ethics
UAE rules on controlled drugs, prescriptions, dispensing and professional conduct
Medication safety and toxicology
High-alert drugs, look-alike sound-alike names, common poisonings and antidotes
Which books are best for the DHA Pharmacist exam?
Book or resource
Use it for
Applied Therapeutics (Koda-Kimble and Young's)
Case-based pharmacotherapy, close to the exam style
Pharmacotherapy: A Pathophysiologic Approach (DiPiro)
Deeper reading on difficult disease areas
Comprehensive Pharmacy Review (Shargel)
Quick revision across the whole syllabus
Pharmaceutical Calculations (Ansel)
Daily calculation practice
BNF or Lexicomp
Doses, interactions and cautions while you study
UAE Federal Law No. 8 of 2019 (medical products and pharmacy profession)
The law and ethics questions
Use one main text and go to the others only for chapters you find weak. Calculations catch out more pharmacists than any clinical topic, so do a few every day from week one.
Which DHA Pharmacist topics are high yield?
Spotting a serious interaction in a two-prescription case and choosing the safest action
Renal dose adjustment using creatinine clearance
Paediatric suspension volumes per dose
Antibiotic choice for common infections and penicillin allergy alternatives
Anticoagulants: warfarin interactions, INR targets and DOAC dosing
OTC requests that need referral instead of a sale
DHA Pharmacist sample practice questions
Each question below is taken from the QBank and reviewed by our doctors. Tap a question to see the answer with the same full explanation you get in the QBank.
Question 1: Clinical pharmacotherapy
A 63-year-old woman has taken omeprazole 40 mg daily for 7 years. She is admitted to a ward in Dubai with muscle cramps and carpopedal spasm. Corrected calcium 1.85 mmol/L, magnesium 0.32 mmol/L, potassium 3.1 mmol/L, phosphate normal, PTH 2.0 pmol/L (inappropriately low-normal), 25-hydroxyvitamin D 60 nmol/L. Calcium remains low despite two doses of IV calcium gluconate. What is the most appropriate next step?
A) Give further intravenous calcium gluconate boluses B) Give intravenous magnesium sulfate C) Start calcitriol D) Start intravenous potassium phosphate
Calcium is normally defended by PTH, which increases bone resorption, distal tubular calcium reabsorption and renal 1-alpha-hydroxylase (making calcitriol). PTH secretion depends on magnesium: severe hypomagnesaemia (below about 0.5 mmol/L) inhibits PTH release and causes end-organ resistance to PTH. So her PTH is inappropriately low despite hypocalcaemia, and calcium will not stay up until magnesium is replaced. Long-term PPIs reduce active intestinal magnesium absorption (TRPM6/7 channels), a recognised regulatory warning. Hypomagnesaemia also causes refractory hypokalaemia through renal potassium wasting. Give IV magnesium sulfate (e.g. 2 g, about 8 mmol), then oral or further IV replacement, monitor levels, and review the PPI: consider stopping, lowering the dose or switching to an H2-receptor antagonist.
Exam pearl: Check magnesium in any patient with hypocalcaemia or hypokalaemia that does not respond to replacement; PPIs, loop and thiazide diuretics, alcohol, cisplatin and aminoglycosides are common causes.
Bone resorption, distal Ca2+ reabsorption, phosphate excretion, 1-alpha-hydroxylase.
PPI warning
Hypomagnesaemia with long-term use, especially with diuretics.
Hypokalaemia link
Low magnesium increases renal potassium loss.
Calcitriol
Increases intestinal calcium and phosphate absorption.
How else this could be askedHIGH-YIELD · EXAM FAVOURITE Menu
Examiners often test the same topic from a different angle: a new clinical scenario, the next step in management, or the underlying mechanism. If you can answer all of these, you have mastered this topic.
"Electrolyte needed for PTH secretion?"➜ Magnesium
"Where does PTH stimulate calcitriol formation?"➜ Renal proximal tubule (1-alpha-hydroxylase)
"Drug class linked to hypomagnesaemia with long-term use?"➜ Proton pump inhibitors
"Why does hypokalaemia fail to correct in hypomagnesaemia?"➜ Renal potassium wasting through ROMK channels
"Acid-suppressant alternative to a PPI in this patient?"➜ H2-receptor antagonist (e.g. famotidine)
Sources: Hall JE, Hall ME. Guyton and Hall Textbook of Medical Physiology. Elsevier; Boron WF, Boulpaep EL. Medical Physiology. Elsevier; US FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of proton pump inhibitor drugs (PPIs), 2011; BNF: Magnesium sulfate.
Question 2: Drug interactions
A 55-year-old woman with a VRE wound infection is started on linezolid 600 mg twice daily. She has taken sertraline 100 mg daily for depression for 2 years. On day 3 she becomes agitated and sweaty, with temperature 38.4 degrees C, tremor, hyperreflexia and inducible ankle clonus. What is the pharmacological basis of this reaction?
A) Linezolid inhibits CYP2D6 and raises sertraline levels B) Linezolid blocks dopamine D2 receptors C) Linezolid is a reversible non-selective monoamine oxidase inhibitor D) Linezolid releases histamine from mast cells
CLinezolid is a reversible non-selective monoamine oxidase inhibitor
Linezolid, an oxazolidinone, kills bacteria by binding the 50S subunit (23S rRNA) and preventing formation of the 70S initiation complex. It is also a weak, reversible, non-selective MAO inhibitor (MAO-A and MAO-B). With an SSRI such as sertraline, serotonin breakdown is reduced while reuptake is blocked, so synaptic serotonin rises. Her agitation, hyperthermia, sweating, tremor, hyperreflexia and inducible clonus meet the Hunter criteria for serotonin syndrome. Management: stop linezolid (and the SSRI), give supportive care and benzodiazepines, and cyproheptadine if moderate. Where linezolid is essential, the SSRI should ideally be stopped first with close monitoring. Linezolid is not a significant CYP inhibitor.
Exam pearl: Linezolid is a weak MAO inhibitor: interactions with SSRIs, SNRIs, TCAs, pethidine, tramadol, triptans, sympathomimetics and tyramine-rich foods.
Binds 23S rRNA of 50S, blocks 70S initiation complex.
Tyramine
Avoid large amounts of aged cheese, cured meats, soy sauce.
Bioavailability
About 100% oral: easy IV to oral switch.
Spectrum
MRSA, VRE, Gram-positives; no useful Gram-negative activity.
How else this could be askedHIGH-YIELD · EXAM FAVOURITE Menu
Examiners often test the same topic from a different angle: a new clinical scenario, the next step in management, or the underlying mechanism. If you can answer all of these, you have mastered this topic.
"Clinical sign most specific for serotonin syndrome?"➜ Inducible or spontaneous clonus
"Diagnostic criteria used?"➜ Hunter criteria
"Antidote for moderate serotonin syndrome?"➜ Cyproheptadine
"Ribosomal target of linezolid?"➜ 23S rRNA of 50S subunit
"Dietary amine to limit on linezolid?"➜ Tyramine
Sources: Preston CL, ed. Stockley's Drug Interactions: linezolid plus SSRIs; Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005; Nelson LS et al. Goldfrank's Toxicologic Emergencies; Joint Formulary Committee. British National Formulary (BNF): linezolid.
Question 3: Medication safety
A hospital in Dubai uses profiled automated dispensing cabinets (ADCs): nurses can remove a dose only after a pharmacist has verified the order, except for drugs on an approved override list. The medication safety committee is reviewing the list. Which medicine is most appropriate to keep on the override list?
A) Vancomycin injection B) Naloxone injection C) Enoxaparin injection D) Warfarin tablets
A profiled ADC links to the pharmacy system so a dose can be removed only for an order that a pharmacist has reviewed. Override bypasses this review and should be limited to situations where the delay of review would harm the patient, such as emergencies. ASHP and ISMP recommend a short, committee-approved override list and regular audit of override use. Naloxone is used for opioid-induced respiratory depression, where minutes matter, so it fits the list. Vancomycin, enoxaparin and warfarin need dose checks against weight, renal function, INR or levels; errors cause serious harm and their first doses can usually wait for a pharmacist review.
Exam pearl: Audit override reports regularly: frequent overrides of non-emergency drugs signal unsafe practice or slow pharmacist verification.
How else this could be askedHIGH-YIELD · EXAM FAVOURITE Menu
Examiners often test the same topic from a different angle: a new clinical scenario, the next step in management, or the underlying mechanism. If you can answer all of these, you have mastered this topic.
"What does a profiled ADC require before removal?"➜ Pharmacist verification of the order
"Who approves the override list?"➜ P&T or medication safety committee
"How to monitor override misuse?"➜ Regular audit of override reports
"Is warfarin suitable for override?"➜ No: high-alert, not an emergency drug
Sources: ASHP Guidelines on the Safe Use of Automated Dispensing Cabinets. Am J Health-Syst Pharm; ISMP Guidelines for the Safe Use of Automated Dispensing Cabinets. 2019.
Question 4: Patient counselling
A 66-year-old man with COPD is assessed for long-term oxygen therapy in Dubai. On two occasions 3 weeks apart, when stable, his PaO2 on air was 7.1 kPa (53 mmHg). He has stopped cigarettes but tells the pharmacist that he still smokes shisha with friends most evenings and sometimes at home. Which is the most appropriate action by the pharmacist?
A) Explain the fire and burn risk, offer cessation support and inform the respiratory team before oxygen is supplied B) Supply the oxygen concentrator and advise him to remove the nasal cannula only while smoking shisha C) Reassure him that shisha is filtered through water so it does not create a risk with oxygen D) Recommend nocturnal oxygen only so that evening shisha is not a problem
AExplain the fire and burn risk, offer cessation support and inform the respiratory team before oxygen is supplied
He meets the LTOT criterion (stable PaO2 of 7.3 kPa (55 mmHg) or less on two readings at least 3 weeks apart). LTOT for at least 15 hours a day improves survival in severe resting hypoxaemia. However, smoking near oxygen causes facial burns, house fires and deaths, and NICE advises not offering LTOT to people who continue to smoke despite cessation support. Shisha uses burning charcoal and a naked flame, so it carries the same fire risk and also delivers carbon monoxide and tobacco toxins. The pharmacist should explain the risk clearly, offer behavioural support and pharmacotherapy, and tell the prescriber so a formal risk assessment is done before supply.
Exam pearl: LTOT criteria in COPD: PaO2 7.3 kPa or less, or 7.3 to 8.0 kPa with polycythaemia, peripheral oedema or pulmonary hypertension. Use for at least 15 hours/day.
No smoking, shisha, candles or gas cookers near oxygen.
Assessment
Two ABGs at least 3 weeks apart when stable.
Shisha
One session can deliver more CO and smoke than many cigarettes.
Hours
Benefit needs 15 hours a day or more.
How else this could be askedHIGH-YIELD · EXAM FAVOURITE Menu
Examiners often test the same topic from a different angle: a new clinical scenario, the next step in management, or the underlying mechanism. If you can answer all of these, you have mastered this topic.
"PaO2 threshold for LTOT in COPD?"➜ 7.3 kPa (55 mmHg) or less
"Minimum daily use for survival benefit?"➜ 15 hours
"Main safety risk with oxygen at home?"➜ Fire from smoking or open flames
"Is shisha a fire risk with oxygen?"➜ Yes, burning charcoal
"How many ABGs to confirm need?"➜ Two, at least 3 weeks apart
Sources: NICE NG115: COPD in over 16s: diagnosis and management (long-term oxygen therapy); Hardinge M et al. BTS guidelines for home oxygen use in adults. Thorax 2015; Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report 2025.
Want more practice?
Try 30 free questions from the same QBank, each with a full explanation. No payment card needed.
How should you plan your DHA Pharmacist preparation?
When
What to do
Weeks 1 to 2
Start with the content areas you use least at work. Do 30 to 40 questions a day on the same areas.
Weeks 3 to 5
Cover the remaining areas one by one and keep a short notes file of every question you get wrong.
Weeks 6 to 7
Mixed timed blocks of 50 questions; go back over the weak areas in your notes file.
Week 8
Two full 150-question papers at exam pace, then light revision only.
Reading alone is not enough, because the paper tests decisions. Practise with the DHA Pharmacist exam questions: 3,000 questions in the same case style, each with an explanation.
Frequently Asked Questions
How long should I prepare for the DHA Pharmacist exam?
Most working pharmacists need 8 to 10 weeks of steady study, with daily questions and two full timed papers at the end.
Are there official DHA Pharmacist past papers?
No. DHA does not release past papers. The CBT guideline in Sheryan lists the content areas and references, and a question bank built on the current pattern is the closest practice.
Are calculations important in the DHA Pharmacist exam?
Yes. Expect several calculation questions on doses, dilutions and infusion rates. They are easy marks if you practise them daily.
Do I need to study UAE pharmacy law?
Yes, at a basic level: controlled drug rules, prescription requirements and professional conduct. A few questions usually test these.
Practise the DHA Pharmacist syllabus
3,000 exam-style questions with explanations, sorted by topic, plus timed mock papers.